相关实验视频

Updated: Jun 15, 2025

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

慢性病非透析患者的新陈代谢评估

Hao Hong¹, Suya Zhou², Junyao Zheng³

¹Department of Intensive Care Unit, The First Affiliated Hospital of Soochow University, Soochow, Suzhou, People's Republic of China.

Journal of inflammation research

|August 23, 2024

概括

这项研究确定了六种关键代谢物,包括ADMA和Kynurenine,作为慢性病 (CKD) 进展的潜在早期生物标志物. 这些发现突显了代谢途径的变化,并有助于早期CKD干预.

科学领域:

生物化学生物化学
代谢学代谢学代谢学
腎臟病學 (nephrology) 是一種醫學專業.

背景情况:

慢性病 (CKD) 影响全球数以百万计的人,通常是默默地进展.
早期发现CKD进展对于及时干预和改善患者结果至关重要.
代谢学提供了一种强大的方法来识别疾病监测的新生物标志物.

研究的目的:

调查非透析CKD患者体液中的代谢变化.
使用代谢学识别早期的生物标志物,这些生物标志物表明CKD进展.
分析相关的代谢途径,以更深入地了解CKD病原性.

主要方法:

分析了47名CKD患者 (1-4阶段) 和30名健康对照者的血样本.
使用了液体染色学-质谱学 (LC-MS) 与多变量数据分析 (OPLS-DA) 相结合.
使用Met PA数据库进行了代谢途径分析.

主要成果:

一个独特的代谢特征使CKD患者与对照人群有所区别.
六种化合物 (ADMA,D-ornithine,Kynurenine,Kynurenic acid,5-Hydroxyindoleacetic acid,Gluconic acid) 与CKD进展有关. 这些化合物与CKD进展有关.
关键的改变的代谢途径包括氨酸/甲氨酸,酸和酸途径.

结论:

特定的代谢物可以作为CKD进展的早期生物标志物.
代谢途径分析提供了对CKD病原体的洞察.
这些发现支持早期干预策略和对CKD的进一步研究.

关键词:

氨酸和氨酸的新陈代谢生物标志物生物标志物酸酸盐路径的酸路径托的代谢过程

更多相关视频

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes

Published on: January 7, 2013

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

相关概念视频

Factors Affecting Renal Clearance: Renal Impairment

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

Dialysis

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

Renal Failure: Dose Adjustments

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...